Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma
Clinical trial NCT05842707 · RECRUITING
Trial details
- NCT number
- NCT05842707
- Sponsor
- Aibin Liang，MD，Ph.D.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-18
- Primary completion
- 2028-01-18
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.